Search Orphan Drug Designations and Approvals
-
Generic Name: | Cytomegalovirus immune globulin intravenous (human) |
---|---|
Date Designated: | 01/28/1991 |
Orphan Designation: | For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bayer Corporation Pharmaceutical Division, Biological Products 400 Morgan Lane New Haven, Connecticut 06516 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-